KU Hematology & Medical Oncology Review 2019

 

KU Hematology & Medical Oncology Review 2019
M

What Is CAR T-Cell Therapy? Overcoming Limitations of Current CARs, Review of Related Trials & Reasons for Treatment Failure

By KU Hematology & Medical Oncology Review 2019 FEATURING Marc Hoffmann
By KU Hematology & Medical Oncology Review 2019 FEATURING Marc Hoffmann
422 views
September 25, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
General
29:33

What Is CAR T-Cell Therapy? Overcoming Limitations of Current CARs, …

KU Hematology & Medical Oncology Review 2019

M. Hoffmann

422 views
25:46

KU ASCO 2019: New Drug Developments in Oncology: Change of How Drugs…

KU Hematology & Medical Oncology Review 2019

J. Baranda

275 views